天然免疫系统与新生隐球菌感染

摘要/Abstract

摘要：

天然免疫系统是宿主免疫防御体系中对抗微生物侵染的第一道屏障。天然免疫细胞通过模式识别受体(pattern recognition receptors,PRRs)识别外源微生物及其成分,其中NOD样受体(NOD like receptors,NLRs)是定位于细胞内的一类PRRs。NLRP1、NLRP3和 NLRC4等NLRs家族成员可以形成叫做炎症小体的分子复合体,介导炎症因子IL-1β和IL-18的成熟。目前已经确定多种炎症小体参与抗真菌的免疫反应。新生隐球菌是一种重要的条件性致病真菌,该菌主要感染AIDS等免疫缺陷患者,感染死亡率很高。目前,人们对天然免疫系统抗新生隐球菌的机制有了一定的了解。该文将对宿主抗新生隐球菌的天然免疫机制进行总结。

关键词: 天然免疫, 炎症, 炎症小体, 真菌, 新生隐球菌

Abstract:

Innate immunity is the first line of the host immune system fighting against invading pathogens.Pattern recognition receptors (PRRs) are responsible for recognition of pathogens and their components.And the nucleotide oligomerization domain (Nod)-like receptors (NLRs) are intracellular PRRs.In recognition of pathogens infection, some NLRs including NLRP3, NLRP1 and NLRC4 form large protein complexes called inflammasomes, which mediate maturation of pro-inflammatory cytokines IL-1β and IL-18.Inflammasomes are important in anti-fungal immunity.Cryptococcus neoformans is an opportunistic fungal pathogen, mainly infecting immunocompromised patients and causing high mortality.Here we review recent progresses on host innate immune response against Cryptococcus neoformans.

Key words: innate immunity, inflammation, inflammasome, fungi, Cryptococcus neoformans

中图分类号:

R519.4

孟广勋, 郭彩琴, 陈明宽. 天然免疫系统与新生隐球菌感染[J]. 中国真菌学杂志, 2015, 10(4): 193-196.

MENG Guang-xun, GUO Cai-qin, CHEN Ming-kuan. Progress on the study of innate immune response to Cryptococcus neoformans[J]. Chinese Journal of Mycology, 2015, 10(4): 193-196.

参考文献

[1] Dostert C,Pétrilli V,Van Bruggen R,et al.Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica[J].Science,2008,320(5876):674-677.
[2] Medzhitov R.Approaching the asymptote:20 years later[J].Immunity,2009,30(6):766-775.
[3] Iwasaki A,Medzhitov R.Toll-like receptor control of the adaptive immune responses[J].Nat Immunol,2009,5(10):987-995.
[4] Brown GD.Dectin-1:a signalling non-TLR pattern-recognition receptor[J].Nat Rev Immunol,2006,6(1):33-43.
[5] Akira S,Takeda K.Toll-like receptor signalling[J].Nat Rev Immunol,4(7):499-511.
[6] Gazi U,Rosas M,Singh S,et al.Fungal recognition enhances mannose receptor shedding through dectin-1 engagement[J].J Biol Chem,2011,286(10):7822-7829.
[7] Akira S,Uematsu S,Takeuchi O.Pathogen recognition and innate immunity[J].Cell,2006,124(4):783-801.
[8] Shoham S,Huang C,Chen JM,et al.Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule[J].J Immunol,2001,166(7):4620-4626.
[9] Mansour MK,Latz E,Levitz SM.Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells[J].J Immunol,2006,176:(5)3053-3061.
[10] Giles SS,Dagenais TR,Botts MR,et al.Elucidating the pathogenesis of spores from the human fungal pathogen Cryptococcus neoformans[J].Infect Immun,2009,77(8):3491-3500.
[11] Guo C,Chen M,Fa Z,et al. Acapsular Cryptococcus neoformans activates the NLRP3 inflammasome[J].Microbes Infect,2014,16(10):845-854.
[12] Kelly RM,Chen J,Yauch LE,et al.Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans[J].Infect Immun,2005,73(1):592-598.
[13] Davis MJ,Eastman AJ,Qiu Y,et al.Cryptococcus neoformans-Induced macrophage lysosome damage crucially contributes to fungal virulence[J].J Immunol,2015,194:(5)2219-2231.
[14] Velagapudi R,Hsueh YP,Geunes-Boyer S,et al.Spores as infectious propagules of Cryptococcus neoformans[J].Infect Immun,2009,77(10):4345-4355.
[15] Dromer F,Ronin O,Dupont B.Isolation of Cryptococcus neoformans var.gattii from an Asian patient in France:evidence for dormant infection in healthy subjects[J].J Med Vet Mycol,1992,30(5):395-397.
[16] Garcia-Hermoso D,Janbon G,Dromer F.Epidemiological evidence for dormant Cryptococcus neoformans infection[J].J Clin Microbiol,1999,37(10):3204-3209.
[17] Singh N,Alexander BD,Lortholary O,et al.Pulmonary cryptococcosis in solid organ transplant recipients:Clinical relevance of serum cryptococcal antigen[J].Clin Infect Dis,2008,46(2):E12-E18.
[18] Hoang LM,Maguire JA,Doyle P,et al.Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre(1997-2002):epidemiology,microbiology and histopathology[J].J Med Microbiol,2004,53(Pt 9):935-940.
[19] Zaragoza O,Rodrigues ML,De Jesus M,et al.The capsule of the fungal pathogen Cryptococcus neoformans[J].Adv Appl Microbiol,2009,68:133-216.
[20] Kozel TR,Gotschlich EC.The capsule of Cryptococcus-neoformans passively inhibits phagocytosis of the yeast by macrophages[J].J Immunol,1982,129(4):1675-1680.
[21] Levitz SM,Tabuni A.Binding of Cryptococcus neoformans by human cultured macrophages.Requirements for multiple complement receptors and actin[J].J Clin Invest,1991,87(2):528-535.
[22] Walenkamp AM,Chaka WS,Verheul AF,et al.Cryptococcus neoformans and its cell wall components induce similar cytokine profiles in human peripheral blood mononuclear cells despite differences in structure[J].FEMS Immunol Med Microbiol,1999,26(3-4):309-318.
[23] Vecchiarelli A,Retini C,Monari C,et al.Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes[J].Infect Immun,1996,64(7):2846-2849.
[24] Moyrand F,Fontaine T,Janbon G.Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence[J].Mol Microbiol,2007,64(3):771-781.
[25] Pietrella D,Lupo P,Bistoni F,et al.An early imbalance of interleukin 12 influences the adjuvant effect of mannoproteins of Cryptococcus neoformans[J].Cell Microbiol,2004,6(9):883-891.
[26] Orendi JM,Verheul AF,De Vos NM,et al.Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication[J].Clin Exp Immunol,1997,107(2):293-299.
[27] Kozel TR,Gotschlich EC.The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages[J].J Immunol,1982,129(4):1675-1680.
[28] Kozel TR,Highison B,Stratton CJ.Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils[J].Infect Immun,1984,43(2):574-579.
[29] Shao X,Mednick A,Alvarez M,et al.An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia[J].J Immunol,175(5):3244-3251.
[30] Tucker SC,Casadevall A.Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm[J].Proc Natl Acad Sci USA,2002,99(5):3165-3170.
[31] Alvarez M,Casadevall A.Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages[J].BMC Immunol,2007,8:16.
[32] Bach MC,Tally PW,Godofsky EW.Use of cerebrospinal fluid shunts in patients having acquired immunodeficiency syndrome with cryptococcal meningitis and uncontrollable intracranial hypertension[J].Neurosurgery,1997,41(6):1280-1282.
[33] Banerjee U,Gupta K,Venugopal P.A case of prosthetic valve endocarditis caused by Cryptococcus neoformans var.neoformans[J].J Med Vet Mycol,1997,35(2):139-141.
[34] Walsh TJ,Schlegel R,Moody MM,et al.Ventriculoatrial shunt infection due to Cryptococcus neoformans:an ultrastructural and quantitative microbiological study[J].Neurosurgery,1986,18(6):373-375.
[35] Lei G,Chen M,Li H,et al.Biofilm from a clinical strain of Cryptococcus neoformans activates the NLRP3 inflammasome[J].Cell Res,2013,23(7):965-968.
[36] Nakamura K,Miyazato A,Xiao G,et al.Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway[J].J Immunol,208,180(6):4067-4074.